ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Dallas, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Colorectal Cancer
Cancer
Uterine Cervical Cancer
Stomach Cancer

Endometrial Cancer trials near Dallas, TX, USA:

A Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer in Adjuvant Setting

and safety of T-DXd adjuvant therapy, with or without radiotherapy, post-surgery in anticancer treatment naïve (including neoadjuvant therapy) endometrial...

Enrolling
Endometrial Cancer
Drug: Trastuzumab Deruxtecan
Drug: Chemotherapy

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Bedford, Texas, United States and 85 other locations

study to assess safety, tolerability, pharmacokinetics, immunogenicity, and antitumor activity of ARR-002 in advanced or metastatic ovarian or endometrial...

Enrolling
Endometrial Cancer
Metastatic Ovarian Cancer
Drug: ARR-002

Phase 1

ArriVent BioPharma
ArriVent BioPharma

Irving, Texas, United States of America and 5 other locations

(MMR) system, that fixes genetic mistakes. In most endometrial cancers, this system works normally, and these cancers are ...

Enrolling
Endometrial Cancer
Endometrial Neoplasms
Biological: Pembrolizumab
Drug: Standard of Care Chemotherapy

Phase 3

Pfizer
Pfizer

Irving, Texas, United States and 53 other locations

(ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial...

Enrolling
Endometrioid Endometrial Cancer
Drug: Letrozole 2.5mg
Drug: Narazaciclib

Phase 1, Phase 2

Traws Pharma, Inc.

Dallas, Texas, United States and 7 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Fort Worth, Texas, United States and 255 other locations

(paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial...

Active, not recruiting
Endometrial Neoplasms
Drug: Carboplatin
Biological: durvalumab

Phase 3

AstraZeneca
AstraZeneca

Dallas, Texas, United States and 201 other locations

This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...

Enrolling
Endometrial Cancer
Drug: Navtemadlin
Drug: Navtemadlin Placebo

Phase 2, Phase 3

Kartos Therapeutics
Kartos Therapeutics

Fort Worth, Texas, United States and 83 other locations

Locations recently updated

standard medical care for the treatment of recurrent or progressive endometrial cancer (EC) following prior therapy. There is an eq...

Enrolling
Endometrial Cancer
Recurrent or Progressive Endometrial Cancer
Drug: Rina-S
Drug: IC

Phase 3

Genmab
Genmab

Dallas, Texas, United States and 179 other locations

participants with recurrent or primary advanced (Stage III or IV) endometrial cancer....

Active, not recruiting
Neoplasms
Drug: Paclitaxel
Drug: Carboplatin

Phase 3

Tesaro
Tesaro

Dallas, Texas, United States and 168 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Dallas, Texas, United States and 188 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems